Revolution Medicines, Inc.
RVMD
$39.12
$0.090.23%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | 23.95% | 1,087.88% | |||
Gross Profit | -23.95% | -1,087.88% | |||
SG&A Expenses | 17.75% | 10.36% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 23.10% | 12.17% | |||
Operating Income | -23.10% | -12.17% | |||
Income Before Tax | -24.98% | -17.30% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -24.49% | -17.30% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -24.49% | -17.30% | |||
EBIT | -23.10% | -12.17% | |||
EBITDA | -23.27% | -12.37% | |||
EPS Basic | -19.55% | -16.10% | |||
Normalized Basic EPS | -20.00% | -16.12% | |||
EPS Diluted | -19.55% | -16.10% | |||
Normalized Diluted EPS | -20.00% | -16.12% | |||
Average Basic Shares Outstanding | 4.14% | 1.03% | |||
Average Diluted Shares Outstanding | 4.14% | 1.03% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |